Neoantigens from the bench to the bedside: new prospective for ovarian cancer immunotherapy

被引：1
作者：
Napoletano, Chiara [1 ]
Bellati, Filippo [2 ]
机构：
[1] Univ Rome Sapienza, Dept Expt Med, Rome, Italy
[2] Univ Rome Sapienza, St Andrea Hosp, Surg & Med Dept Translat Med, Rome, Italy
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2019年 / 7卷
关键词：
T-CELLS; CARCINOMA; PROGNOSIS;
D O I：
10.21037/atm.2019.10.62
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 20 条
[1]   Specific immunotherapy in ovarian cancer: a systematic review [J].
Alipour, Soroush ;
Zoghi, Samaneh ;
Khalili, Nastaran ;
Hirbod-Mobarakeh, Armin ;
Emens, Leisha A. ;
Rezaei, Nima .
IMMUNOTHERAPY, 2016, 8 (10) :1193-1204
[2]   Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: Clinical and immunological data of a phase I/II clinical trial [J].
Antonilli, Morena ;
Rahimi, Hassan ;
Visconti, Valeria ;
Napoletano, Chiara ;
Ruscito, Ilary ;
Zizzari, Ilaria Grazia ;
Caponeto, Salvatore ;
Barchiesi, Giacomo ;
Iadarola, Roberta ;
Pierelli, Luca ;
Rughetti, Aurelia ;
Bellati, Filipo ;
Panici, Pierluigi Benedetti ;
Nuti, Mariana .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 48 (04) :1369-1378
[3]   The development and use of vascular targeted therapy in ovarian cancer [J].
Chase, Dana M. ;
Chaplin, David J. ;
Monk, Bradley J. .
GYNECOLOGIC ONCOLOGY, 2017, 145 (02) :393-406
[4]   Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss [J].
Clarke, Blaise ;
Tinker, Anna V. ;
Lee, Cheng-Han ;
Subramanian, Subbaya ;
van de Rijn, Matt ;
Turbin, Dmitry ;
Kalloger, Steve ;
Han, Guangming ;
Ceballos, Kathy ;
Cadungog, Mark G. ;
Huntsman, David G. ;
Coukos, George ;
Gilks, C. Blake .
MODERN PATHOLOGY, 2009, 22 (03) :393-402
[5]   Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival [J].
Curiel, TJ ;
Coukos, G ;
Zou, LH ;
Alvarez, X ;
Cheng, P ;
Mottram, P ;
Evdemon-Hogan, M ;
Conejo-Garcia, JR ;
Zhang, L ;
Burow, M ;
Zhu, Y ;
Wei, S ;
Kryczek, I ;
Daniel, B ;
Gordon, A ;
Myers, L ;
Lackner, A ;
Disis, ML ;
Knutson, KL ;
Chen, LP ;
Zou, WP .
NATURE MEDICINE, 2004, 10 (09) :942-949
[6]   PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer [J].
Ding, Liya ;
Kim, Hye-Jung ;
Wang, Qiwei ;
Kearns, Michael ;
Jiang, Tao ;
Ohlson, Carolynn E. ;
Li, Ben B. ;
Xie, Shaozhen ;
Liu, Joyce F. ;
Stover, Elizabeth H. ;
Howitt, Brooke E. ;
Bronson, Roderick T. ;
Lazo, Suzan ;
Roberts, Thomas M. ;
Freeman, Gordon J. ;
Konstantinopoulos, Panagiotis A. ;
Matulonis, Ursula A. ;
Zhao, Jean J. .
CELL REPORTS, 2018, 25 (11) :2972-+
[7]   Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis [J].
Hwang, Wei-Ting ;
Adams, Sarah F. ;
Tahirovic, Emin ;
Hagemann, Ian S. ;
Coukos, George .
GYNECOLOGIC ONCOLOGY, 2012, 124 (02) :192-198
[8]  
LIU S, 2019, J IMMUNOTHER CANCER, V7
[9]   IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance [J].
Munn, David H. ;
Mellor, Andrew L. .
TRENDS IN IMMUNOLOGY, 2016, 37 (03) :193-207
[10]   Bevacizumab-Based Chemotherapy Triggers Immunological Effects in Responding Multi-Treated Recurrent Ovarian Cancer Patients by Favoring the Recruitment of Effector T Cell Subsets [J].
Napoletano, Chiara ;
Ruscito, Ilary ;
Bellati, Filippo ;
Zizzari, Ilaria Grazia ;
Rahimi, Hassan ;
Gasparri, Maria Luisa ;
Antonilli, Morena ;
Panici, Pierluigi Benedetti ;
Rughetti, Aurelia ;
Nuti, Marianna .
JOURNAL OF CLINICAL MEDICINE, 2019, 8 (03)
12